|
 |
| home > epc > winter 2001 > outsourcing your clinical trial - the search for added value |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
From a rational perspective, choosing a clinical research organisation (CRO) should be easy. They are numerous, the competition is high, and the nuts and bolts of all clinical trials are essentially the same. This has created a buyers' market with many clinical research organisations chasing the same work. It would therefore appear that choice of CRO can be determined by two tangible elements, namely price and capacity. To these should be added financial security, evidence of compliance to ICH and some indication that the study staff initiating your project will also be around to see it through to completion.
But is this process really rational? Surely the choice of a CRO should involve a balanced assessment of all potential factors, including those which may be considered 'soft' or difficult to quantify, but which may add significant value to your relationship?
This article will examine the real decisions that have to be made when choosing a contract partner. The examination will involve an honest appraisal of what an organisation should really hope to gain from such a partner in order to add real value to outsourcing activities as opposed to playing safe, basing a decision only on tangibles, and risking a poor return on investment.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trials in Latin America
9-10 September 2010, Lima, Peru
CBI’s Conference on Clinical Trials in Latin America, being held 9–10th September 2010 in Lima, Peru brings together key stakeholders involved with clinical trials in Latin America. Latin America is an increasingly desirable location for running clinical trials, and it is important for those involved to collaborate with colleagues and industry counterparts regarding the challenges of developing, executing and completing clinical trials in Latin America. This is a unique opportunity for pharmaceutical executives in Latin America to hear from key regulatory officials, pharmaceutical leaders, CROs and sites on how all stakeholders in the clinical process can ultimately achieve desired results.
More info >> |
|
 |
News and Press Releases |
 |
mHealth 2010
mHealth 2010 conference and exhibition is the world’s leading independent event for mobile health. See key representatives from across the globe come together for the first time under one roof. The conference takes place from the 13th to 15th September 2010, at the Mövenpick Hotel, Jumeirah Beach, Dubai.
More info >> |
|
 |
